Karron, R. A., Casey, R., Thumar, B., Surman, S., Murphy, B. R., Collins, P. L., & Schmidt, A. C. (2011). The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well-tolerated, infectious, and immunogenic in infants and young children.

Karron, Ruth A., Roberta Casey, Bhagvanji Thumar, Sonja Surman, Brian R. Murphy, Peter L. Collins, et Alexander C. Schmidt. The CDNA-derived Investigational Human Parainfluenza Virus Type 3 Vaccine Rcp45 Is Well-tolerated, Infectious, and Immunogenic in Infants and Young Children. 2011.

Karron, Ruth A., et al. The CDNA-derived Investigational Human Parainfluenza Virus Type 3 Vaccine Rcp45 Is Well-tolerated, Infectious, and Immunogenic in Infants and Young Children. 2011.